Uniplan Investment Counsel’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-71,164
Closed -$1.1M 126
2024
Q2
$1.1M Sell
71,164
-74,946
-51% -$1.24M 0.1% 113
2024
Q1
$2.08M Buy
146,110
+840
+0.6% +$11.5K 0.16% 105
2023
Q4
$1.49M Sell
145,270
-4,808
-3% -$43.2K 0.11% 114
2023
Q3
$1.63M Buy
150,078
+2,322
+2% +$21.3K 0.13% 111
2023
Q2
$1.57M Buy
147,756
+49,528
+50% +$534K 0.11% 112
2023
Q1
$1.31M Sell
98,228
-4,611
-4% -$58.2K 0.09% 113
2022
Q4
$1.39M Buy
102,839
+804
+0.8% +$8.14K 0.1% 110
2022
Q3
$992K Sell
102,035
-755
-0.7% -$9.52K 0.08% 120
2022
Q2
$1.32M Buy
102,790
+34,426
+50% +$456K 0.09% 117
2022
Q1
$952K Buy
68,364
+329
+0.5% +$5.33K 0.06% 128
2021
Q4
$1.12M Buy
68,035
+576
+0.9% +$12K 0.06% 129
2021
Q3
$1.58M Sell
67,459
-821
-1% -$21.9K 0.1% 130
2021
Q2
$1.83M Buy
+68,280
New +$2.11M 0.11% 132

Other funds holding MDWD

Uniplan Investment Counsel's MDWD Position: Q3 2024 in Review

Uniplan Investment Counsel sold out of MediWound (MDWD) in Q3 2024, closing a stake of 71,164 shares — an estimated $1.1M sold.

Uniplan Investment Counsel first reported a position in MDWD in Q2 2021 and held it in 13 quarters. The position peaked at $2.08M in Q1 2024. 63 funds tracked by Wall St. Rank hold MDWD as of Q3 2024.

  • Uniplan Investment Counsel reported no remaining MediWound position as of Q3 2024 after selling out during the quarter.
  • Uniplan Investment Counsel sold 71,164 MediWound shares in Q3 2024, an estimated $1.1M.
  • Uniplan Investment Counsel first reported a position in MediWound in Q2 2021 and held it in 13 quarters.
  • Uniplan Investment Counsel's MediWound position peaked at $2.08M in Q1 2024.
  • 63 funds tracked by Wall St. Rank held MediWound as of Q3 2024.

Based on Uniplan Investment Counsel's 13F filing for Q3 2024, filed 14 Nov 2024.